FREE Account Opening + No Clearing Fees
Loading...

Indian Infotech RI (BSE) review (Avoid)

Indian Infotech And Software Limited Logo

•    The company's name does not indicate its current business operations.
•    It has posted erratic and listless financial performance so far. 
•    Post-RI its equity will be Rs. 126.7 cr. that may raise its servicing issue. 
•    Promoter's holding of 7.04% poses concern.
•    There is no harm in skipping this "High Risk/No Return" bet.

ABOUT COMPANY:
Indian Infotech and Software Ltd. (IISL) is a non-banking finance company ("NBFC") incorporated in the year 1982 registered with the Reserve Bank of India bearing registration number B-13.0022 to carry on NBFC business activities under Section 45IA of the Reserve Bank of India Act, 1934. It is a Non-systemically important non-deposit taking company with over two decades of lending experience in rural and semi-urban geographies in India. The company is primarily engaged in micro centric lending solutions to look after the needs and aspirations of customers. Its portfolio includes Vehicle Finance and Business Finance Products to small business owners. 

It has long history of serving all types of markets with high growth potential and have maintained a track record of financial performance and operational efficiency through consistently high rates of customer acquisition and retention and low cost expansion into underpenetrated areas. Therefore, IISL strategically focuses on clients in the rural and semi urban sector.

It carries out operations in the format of "hub & spoke" business model. The company conducts retail operations through registered office located at Mumbai. In small business finance and vehicle finance businesses, its branches digital presence/ act as the primary point of sale and assist with the origination of loans, various collection processes and enhancing customer service, while its central support office provides support functions, such as loan processing and credit monitoring. As of September 30, 2023, it had 15 employees on its payroll. It is highly surprising that its name does not match with the business it does. 

ISSUE DETAILS:
The company is coming out with Rights Issue (RI) of 261453270 shares of Re. 1 each at a fixed price of Rs. 1.60 per share to mobilize Rs. 41.83. The issue opens for subscription on February 06, 2024, and will close on February 13, 2024. The company is offering RI in the ratio of 13 for 50 to eligible stakeholders as of the record date of January 29, 2024. Full money is to be paid on application for the number of shares applied. Post allotment, shares will be listed on BSE. The company is spending Rs. 0.30 cr. for this RI process and from the net proceeds, it will utilize Rs. 35.00 cr. for working capital, and Rs. 653 cr. for general corporate purposes. 

The issue is self-managed by the company and Purva Sharegistry (India) Pvt. Ltd. is the registrar of the issue. While Link Intime India Pvt. Ltd. is the RTA for the company. 

Post-RI, company's current paid-up equity capital of Rs. 100.56 cr. will stand enhanced to Rs. 126.70 cr. Based on the RI pricing, the company is looking for a market cap of Rs. 202.73 cr. 

FINANCIAL PERFORMANCE:
On the financial performance front, for the last two fiscals, the company reported a total income/net profit of Rs. 55.39 cr. / Rs. 00.32 cr. (FY22), and Rs. 47.06 cr. / Rs. 0.61 cr. (FAY23). For H1 of FY24 it earned a net profit of Rs. 7.21 cr. on a total income of Rs. 10.95 cr. Thus its financial performance has been inconsistent with surprisingly rising bottom lines. There appears to be some window dressing to lure investors for subscribing RI. Looking at negligible profits, it may face servicing issue as its equity will be above Rs. 126 cr. post RI. 

DIVIDEND POLICY:
The company has not declared any dividends for the reported periods of the offer document. It will adopt a prudent dividend policy post listings of RI shares based on its financial performance and future prospects. 

SCRIP PERFORMANCE: BASED ON BSE WEBSITE DATA: SCRIP CODE: 509051 (FV Re. 1).
The scrip last closed on cum-right basis at Rs. 2.88 on January 25, 2024, and opened on an ex-right basis at Rs. 2.55 on January 29, 2024. Since then, it has marked a high/low of Rs. 2.97 / Rs. 2.55. The scrip last closed at Rs. 2.64 as of February 02, 2024. For the last 52 weeks' it has posted a high/low of Rs. 2.97 / Rs. 1.05. 

The promoters' holding has declined from 11.86% as of June 30, 2023 to 7.04% as of December 31, 2023. The counter is well managed above the RI value by vested interest parties to lure investors for investment. 


Conclusion / Investment Strategy

Though this RI is at a discount to its last traded price, it is very high if we compare its financial performance. The name of company does not match with its ongoing activities and is misguiding. Considering poor financial track record and jump in its post-RI paid up equity capital of Rs.126.7 cr., it will have capital servicing issue with minuscule earnings. There is no harm is staying away from this “High Risk/No Return” bet.

Reviewer recommends Avoid to the issue.

Review By Dilip Davda on February 3, 2024

Review Author

DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. Readers must consult a qualified financial advisor before making any actual investment decisions, based on the information published here. My reviews do not cover GMP market and operators game plans. Any reader taking decisions based on any information published here does so entirely at their own risk. Investors should bear in mind that any investment in stock markets is subject to unpredictable market-related risks. The above information is based on RHP and other documents available as of date coupled with market perception. The author has no plans to invest in this offer.


About Dilip Davda

Dilip Davda, a freelance journalist

Dilip Davda is veteran journalist associated with stock market since 1978. He is contributing to print and electronic media on stock markets/insurance/finance since 1985.

Dilip Davda is a leading reviewer of public issues and NCDs in the primary stock market in India. The knowledge he gained over 3 decades while working in the stock market and a strong relationship with popular lead managers makes his reviews unique. His detail fundamental and financial analysis of companies coming up with IPO helps investors in the primary stock market. Dilip Davda has a special interest in analyzing the SME companies and writing reviews about their public issues. His reviews are regularly published online and in news papers.

(Dilip Davda -SEBI registered Research Analyst-Mumbai,

Registration no. INH000003127 (Perpetual)

Email id: dilip_davda@rediffmail.com ).

More Indian Infotech And Software Limited RI Views / Analysis / Recommendations ...

The Indian Infotech And Software Rights Issue 2024 Analysis helps you to understand about the company, offer detail, valuation, capital structure and financial performance. Our SEBI registered Rights Issue Analysts tells you if Indian Infotech And Software Rights Issue 2024 worth investing. The Indian Infotech And Software Rights Issue 2024 Note sets the Rights Issue expectations in systematic way which tells you if Indian Infotech And Software Rights Issue 2024 good to buy (good or bad / yes or no). The Rights Issue Forecast tells you weather to invest in Indian Infotech And Software Rights Issue 2024 by providing Rights Issue recommendations i.e. subscribe, avoid and neutral.


1 Comments

1. Ujjal mandal     Link|February 16, 2024 11:11:52 AM
Indian infotech software re share 130 buy how to apply my re share